“Rather than waiting and hoping for generic drug companies to address this need, we are taking this bold step on behalf of those we are privileged to serve,” Tony Tersigni, CEO of Ascension.
Wow this is a bold move! Does this make my predication below come true?
This will be really exciting to watch but it actually makes for more questions than answers.
Will they sell to other IDNs?
What is next? Devices? Capital equipment? Office supplies?
I’d love to hear your thoughts on this. Email me here with your opinions.
Latest posts by Anna McCormick (see all)
- April 11, 2018 - April 19, 2018
- Michael DeLuca from Prodigo Solutions on Healthcare Supply Chain Radio - April 19, 2018
- 10 Keys for Success in National Accounts in 2018! (Free 10-page e-book available for download now!) - April 19, 2018